1-[(ω-Aminoalkyl)amino]-4-[N-(ω-aminoalkyl)carbamoyl]-9-oxo-9,10-dihydro- acridines as Intercalating Cytotoxic Agents: Synthesis, DNA Binding, and Biological Evaluation
- 1 November 1997
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (23) , 3749-3755
- https://doi.org/10.1021/jm970114u
Abstract
A series of DNA-intercalating potential antitumor agents, 1-[(ω-aminoalkyl)amino]-4-[N-(ω-aminoalkyl)carbamoyl]-9-oxo-9,10-dihydroacridines, has been prepared by aminolysis of the corresponding 4-[N-(ω-aminoalkyl)carbamoyl]-1-chloro derivative with a suitable ω-aminoalkylamine. The noncovalent DNA-binding properties of these bis-functionalized compounds have been examined using a combination of fluorometric and thermal denaturation techniques and are compared with the behaviors for established DNA intercalants and cationic minor groove ligands. The results indicate that (i) the agents are considerably more DNA-affinic than less functionalized acridinones, with ‘apparent' binding constants of (0.1−2.1) × 107 and (0.3−7.5) × 107 M-1 at pH 5 and 7, respectively, (ii) overall affinity is sensitive to both the length of the flexible side chain and the complexity of the attached amine substituents, and (iii) the pendant side chains effect a switch to moderate AT-preferential binding. In vitro cytotoxic potencies toward six tumor cell lines broadly parallel the observed DNA affinities, although poor correlation is evident for certain compounds. The octanol/water partition coefficients have been also calculated, but there is no correlation with cytotoxicity values. Two highly DNA-affinic analogs, 10 and 13, have been identified with a useful broad spectrum of cytotoxic activity.Keywords
This publication has 15 references indexed in Scilit:
- Novel Acridine-Triazenes as Prototype Combilexins: Synthesis, DNA Binding, and Biological ActivityJournal of Medicinal Chemistry, 1995
- Synthesis of (Dialkylamino)alkyl-Disubstituted Pyrimido[5,6,1-de]acridines, a Novel Group of Anticancer Agents Active on a Multidrug Resistant Cell LineJournal of Medicinal Chemistry, 1995
- Interaction of Minor‐Groove‐Binding Diamidine Ligands with an Asymmetric DNA DuplexEuropean Journal of Biochemistry, 1995
- 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A Novel Class of Chromophore-Modified Antitumor Anthracene-9,10-diones: Synthesis and Antitumor EvaluationsJournal of Medicinal Chemistry, 1994
- 2-(Aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agentsJournal of Medicinal Chemistry, 1992
- Kinetic analysis of protein kinase C: product and dead-end inhibition studies using ADP, poly(L-lysine), nonhydrolyzable ATP analogs, and diadenosine oligophosphatesBiochemistry, 1991
- Design, Synthesis, DNA Binding, and Biological Activity of a Series of DNA Minor-Groove-Binding Intercalating DrugsJournal of Pharmaceutical Sciences, 1989
- Heteroarenobenzodiazepines. 6. Synthesis and pharmacological evaluation of CNS activities of [1,2,3]triazolo[4,5-b][1,5]-, imidazolo[4,5,-b][1,5]-, and pyrido[2,3-b][1,5]benzodiazepines. 10-Piperazinyl-4H-1,2,3-triazolo[4,5-b][1,5]benzodiazepines with neuroleptic activityJournal of Medicinal Chemistry, 1989
- Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenedionesJournal of Medicinal Chemistry, 1979
- Synthesis of 3,4-dihydro-4-oxothieno[2,3-d]pyrimidine-2-carboxylates, a new series of orally active antiallergy agentsJournal of Medicinal Chemistry, 1979